Literature DB >> 30046578

Prevention of post-embolization syndrome after transarterial chemoembolization for hepatocellular carcinoma-is prophylactic dexamethasone useful, or not?

Toru Ishikawa1.   

Abstract

Entities:  

Year:  2018        PMID： 30046578      PMCID： PMC6036066          DOI： 10.21037/hbsn.2018.03.08

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Cytolysis following chemoembolization for hepatocellular carcinoma.

Authors:  S J Wigmore; K K Madhavan; D N Redhead; O J Garden
Journal:  Br J Surg       Date:  1999-08       Impact factor: 6.939

2.  Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

Authors:  Zhi-Liang Huang; Jun Luo; Min-Shan Chen; Jin-Qing Li; Ming Shi
Journal:  J Vasc Interv Radiol       Date:  2011-05       Impact factor: 3.464

3.  Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome.

Authors:  Sabeen Dhand; Ramona Gupta
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

Review 4.  Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver Cancer.

Authors:  Helen Blackburn; Sandra West
Journal:  Cancer Nurs       Date:  2016 Sep-Oct       Impact factor: 2.592

5.  A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization.

Authors:  Sadahisa Ogasawara; Tetsuhiro Chiba; Yoshihiko Ooka; Naoya Kanogawa; Tenyu Motoyama; Eiichiro Suzuki; Akinobu Tawada; Kazue Nagai; Tomoo Nakagawa; Takeshi Sugawara; Hideki Hanaoka; Fumihiko Kanai; Osamu Yokosuka
Journal:  Hepatology       Date:  2017-12-23       Impact factor: 17.425

6.  American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

Authors:  Mark G Kris; Paul J Hesketh; Mark R Somerfield; Petra Feyer; Rebecca Clark-Snow; James M Koeller; Gary R Morrow; Lawrence W Chinnery; Maurice J Chesney; Richard J Gralla; Steven M Grunberg
Journal:  J Clin Oncol       Date:  2006-05-22       Impact factor: 44.544

7.  Dexamethazone-induced acute tumor lysis syndrome in a T-cell malignant lymphoma.

Authors:  R Lerza; M Botta; B Barsotti; E Schenone; M Mencoboni; G Bogliolo; I Pannacciulli; E Arboscello
Journal:  Leuk Lymphoma       Date:  2002-05

Review 8.  Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

Authors:  Luigi Bolondi; Andrew Burroughs; Jean-François Dufour; Peter R Galle; Vincenzo Mazzaferro; Fabio Piscaglia; Jean Luc Raoul; Bruno Sangro
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

9.  Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.

Authors:  Masafumi Ikeda; Yasuaki Arai; Sang Joon Park; Yoshito Takeuchi; Hiroshi Anai; Jae Kyu Kim; Yoshitaka Inaba; Takeshi Aramaki; Se Hwan Kwon; Seiichiro Yamamoto; Takuji Okusaka
Journal:  J Vasc Interv Radiol       Date:  2013-03-07       Impact factor: 3.464

10.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396
View more
  2 in total

Review 1.  Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Guorong Jia; Juno Van Valkenburgh; Austin Z Chen; Quan Chen; Jindian Li; Changjing Zuo; Kai Chen
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-08-17

2.  Identifying predictors and evaluating the role of steroids in the prevention of post-embolization syndrome after transarterial chemoembolization and bland embolization.

Authors:  Rohit Agrawal; Muhammad Majeed; Sheeba-Ba Aqeel; Yuchen Wang; Zohaib Haque; Yazan Abu Omar; Shristi Banskota Upadhyay; Thomas Gast; Bashar M Attar; Seema Gandhi
Journal:  Ann Gastroenterol       Date:  2020-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.